Shanghai - Delayed Quote CNY

Runben Biotechnology Co., Ltd. (603193.SS)

38.69
+1.76
+(4.77%)
At close: May 9 at 3:00:03 PM GMT+8
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
2,219,337.49
2,018,870.92
825,420.20
646,339.48
Total Liabilities Net Minority Interest
138,883.79
97,612.51
102,833.35
84,694.10
Total Equity Gross Minority Interest
2,080,453.70
1,921,258.41
722,586.85
561,645.39
Total Capitalization
2,080,453.70
1,921,258.41
722,586.85
561,645.39
Common Stock Equity
2,080,453.70
1,921,258.41
722,586.85
561,645.39
Capital Lease Obligations
1,417.69
2,042.19
5,393.17
7,907.74
Net Tangible Assets
2,025,915.68
1,902,501.34
703,223.78
541,762.94
Working Capital
1,457,641.92
1,621,209.88
413,444.88
268,841.56
Invested Capital
2,080,453.70
1,921,258.41
722,586.85
561,645.39
Tangible Book Value
2,025,915.68
1,902,501.34
703,223.78
541,762.94
Total Debt
2,783.16
3,996.73
7,907.74
10,308.28
Share Issued
404,593.31
404,593.31
343,903.31
343,903.31
Ordinary Shares Number
404,593.31
404,593.31
343,903.31
343,903.31
12/31/2021 - 10/17/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers